Literature DB >> 729536

Elevation of seizure thresholds: a comparison of cerebellar stimulation, phenobarbital, and diphenylhydantoin.

G M Strain, W G Van Meter, W H Brockman.   

Abstract

Generalized EEG seizures were induced in acute, conscious New Zealand albino rabbits with intravenous pentylenetetrazol (PTZ) (10 or 15 mg/kg) or electrical stimulation of the frontal cerebral cortex (ELEC) (50 Hz, 1 msec pulse duration, 2 sec train duration, 4.0-7.6 V). Three anticonvulsant treatments were compared: (1) electrical transhemispheral stimulation of the ansiform or simplex cerebellar lobes (10 Hz, 1.5 msec, 3-4 V), (2) phenobarbital (PB) (25 mg/kg, i.v.), and (3) diphenylhydantoin (DPH) (30 mg/kg, i.v.). After treatment, increments in PTZ dose or stimulation voltage were applied until a seizure was evoked that approximated the original in severity and duration. PTZ seizure thresholds were not elevated by DPH, and electrically induced seizure thresholds were not elevated by cerebellar stimulation (CBL). The four remaining seizure threshold elevations (increase in PTZ dose or stimulation voltage) were significant at a level of 0.025 or greater. Comparison of the elevations of seizure thresholds showed no differences at the 0.01 level of significance. Thus, no differences were seen between elevation of PTZ seizure thresholds by CBL or PB, or elevation of electrically induced seizure thresholds by PB or DPH, when examined on an acute basis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729536     DOI: 10.1111/j.1528-1157.1978.tb05176.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

Review 1.  The cerebellum and epilepsy.

Authors:  Martha L Streng; Esther Krook-Magnuson
Journal:  Epilepsy Behav       Date:  2020-02-05       Impact factor: 3.337

2.  Cerebellar Directed Optogenetic Intervention Inhibits Spontaneous Hippocampal Seizures in a Mouse Model of Temporal Lobe Epilepsy.

Authors:  Esther Krook-Magnuson; Gergely G Szabo; Caren Armstrong; Mikko Oijala; Ivan Soltesz
Journal:  eNeuro       Date:  2014-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.